# Why women can have higher mortality after heart attack — brief summary

Research does **not** point to a single cause. Most evidence suggests a *cluster* of factors that can raise women’s risk of death or complications after myocardial infarction (MI), especially in younger women, and that many differences shrink after adjusting for age, comorbidities, and care patterns.

## Key contributing factors (evidence-based)

1. **Older age and more comorbidities at presentation**
   Women tend to present at older ages and with higher burdens of conditions such as diabetes, hypertension, and heart failure. These factors worsen outcomes and can explain part (sometimes most) of the observed mortality gap. Studies examining sex differences in MI outcomes emphasize the role of baseline risk and comorbidity profiles. 
   
2. **Symptom differences and delays in recognition/treatment**
   Women more often experience non‑classic symptoms (shortness of breath, nausea, unusual fatigue, jaw/back pain) alongside or instead of classic chest pain. These patterns can lead to slower recognition by patients and clinicians, and delays in diagnosis and reperfusion treatment, which are strongly linked to worse outcomes. 

3. **Diagnostic challenges from non‑obstructive disease**
   Women are disproportionately represented among patients with **MINOCA** (myocardial infarction with non‑obstructive coronary arteries) and microvascular dysfunction. These etiologies can be missed or require different diagnostic pathways than typical obstructive coronary disease, increasing the risk of delayed or suboptimal treatment.

4. **Treatment gaps and lower use of guideline therapies in some settings**
   Evidence from registry and review data indicates that women, particularly those with MINOCA or atypical presentations, are less likely to receive standard secondary‑prevention therapies and may have lower rates of some evidence‑based interventions. These gaps can contribute to poorer outcomes.

5. **Psychosocial and socioeconomic factors**
   In younger women, higher rates of depression, lower income, and other non‑cardiac comorbidities are associated with worse post‑MI outcomes and higher rehospitalization. These factors can affect recovery, adherence, and access to care.

## Bottom line
The higher mortality seen in women after heart attack is *multifactorial*. It reflects a mix of **biologic differences in disease type**, **symptom patterns that delay care**, **differences in treatment and follow‑up**, and **higher baseline risk or comorbidity burden**. Importantly, targeted awareness, faster recognition, and equitable use of guideline therapies can narrow these gaps.

## References

1. NIH (2023). Sex disparities after heart attack (VIRGO study summary). https://www.nih.gov/news-events/nih-research-matters/sex-disparities-after-heart-attack
2. American Heart Association. Heart attack symptoms in women. https://www.heart.org/en/health-topics/heart-attack/warning-signs-of-a-heart-attack/heart-attack-symptoms-in-women
3. BMC Cardiovascular Disorders (2025). Sex differences in outcomes after acute myocardial infarction. https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04713-9
4. JACC Review Topic of the Week (2021). Ischemic heart disease in young women (MINOCA prevalence and treatment gaps). https://pmc.ncbi.nlm.nih.gov/articles/PMC9847245/
5. MINOCA review (2024). Current insights into pathophysiology, diagnosis, and management (female predominance, microvascular/SCAD mechanisms). https://pmc.ncbi.nlm.nih.gov/articles/PMC11989022/
